Primary

Leading scholars from around the world discuss the administrative law and regulatory dimensions to the global response to COVID-19.

The most surprising regulatory dimension of the coronavirus crisis may center on the lifting of rules.

As COVID-19 persists, governments must decide whether, when, where, and how to hold elections.

To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.

A 70-year old law could help in the battle against the coronavirus outbreak.

A proposed rule to speed up administrative decision-making could have unintended consequences.

Stronger regulations are needed to combat antiquities trafficking that finances terrorist activity.

U.S. food stamp programs grapple with a new wave of scrutiny.

Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.

EPA fails to hold environmental polluters responsible during the COVID-19 crisis.

Trapped at home with their abusers, victims must rely on programs whose long-term funding remains in doubt.

The federal government seeks authority over stem cell treatments but risks thwarting medical advancement.